Home » Topics » Biomarkers, BioWorld Science

Biomarkers, BioWorld Science
RSS

TSHZ3 variants tied to CAKUT

June 13, 2022

Exosomal miR-144-3p identified as potential biomarker of SLE activity

June 13, 2022

FOCAD loss-of-function mutations linked to pediatric liver cirrhosis

June 13, 2022

Circulating miRNAs associated with difficult-to-treat RA

June 10, 2022

High-throughput proteomics identifies biomarkers of both rheumatoid arthritis and SLE

June 9, 2022

Prognostic biomarkers of atherosclerosis and cardiovascular disease in patients with SLE

June 8, 2022

NF1 mutation impacts neurons to modify tumor predisposition by increasing neuronal excitability

June 1, 2022

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

May 24, 2022

DEPDC1-AS1 as novel biomarker for the early detection and prognosis of gastric cancer

May 19, 2022

miR30e-5p is a predictive biomarker of relapse in myasthenia gravis

May 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.